Nextgen Biomed Statistics

Total Valuation

Nextgen Biomed has a market cap or net worth of ILS 6.35 million. The enterprise value is 6.27 million.

Market Cap	6.35M
Enterprise Value	6.27M

Important Dates

The last earnings date was Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Nextgen Biomed has 9.66 million shares outstanding. The number of shares has increased by 3.65% in one year.

Current Share Class	n/a
Shares Outstanding	9.66M
Shares Change (YoY)	+3.65%
Shares Change (QoQ)	+4.82%
Owned by Insiders (%)	18.57%
Owned by Institutions (%)	n/a
Float	7.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.45
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.06

Financial Position

The company has a current ratio of 0.16

Current Ratio	0.16
Quick Ratio	0.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-120.30

Financial Efficiency

Return on equity (ROE) is -341.38% and return on invested capital (ROIC) is -72.09%.

Return on Equity (ROE)	-341.38%
Return on Assets (ROA)	-44.10%
Return on Capital (ROIC)	-72.09%
Revenue Per Employee	n/a
Profits Per Employee	-2.76M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.35% in the last 52 weeks. The beta is 0.85, so Nextgen Biomed's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-50.35%
50-Day Moving Average	67.14
200-Day Moving Average	94.32
Relative Strength Index (RSI)	49.96
Average Volume (20 Days)	24,804

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-4.81M
Pretax Income	-13.82M
Net Income	-13.81M
EBITDA	-4.79M
EBIT	-4.81M
Earnings Per Share (EPS)	-1.85

Full Income Statement

Balance Sheet

The company has 210,000 in cash and 248,000 in debt, giving a net cash position of -38,000 or -0.00 per share.

Cash & Cash Equivalents	210,000
Total Debt	248,000
Net Cash	-38,000
Net Cash Per Share	-0.00
Equity (Book Value)	-2.06M
Book Value Per Share	-0.25
Working Capital	-2.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.95 million and capital expenditures -100,000, giving a free cash flow of -3.05 million.

Operating Cash Flow	-2.95M
Capital Expenditures	-100,000
Free Cash Flow	-3.05M
FCF Per Share	-0.32

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nextgen Biomed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.65%
Shareholder Yield	-3.65%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on September 3, 2023. It was a reverse split with a ratio of 0.1666666667.

Last Split Date	Sep 3, 2023
Split Type	Reverse
Split Ratio	0.1666666667

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a